Get to know our clinical trials
Clinical trial with M281 in adults with autoimmune hemolytic anemia due to warm antibodies: a multicenter, randomized, double-blind, placebo-controlled study.
THE OBJECTIVE OF THE STUDY IS TO EVALUATE THE EFFICACY OF M281 IN PATIENTS WITH WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA (AHAIAC).
Specialist
Hematology and Hemotherapy Department
Navarre headquarters
Status
In recruitment
headquarters
Pamplona
Technical Summary
- Code EudraCT: 2019-000720-17
- Protocol number: MOM-M281-006
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
More information about this clinical trial
Information offered by the Spanish Registry of Clinical Studies
- Summary
- Information
- Calendar
- Headquarters
- Drugs
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.